II. Technique
- See Arterial Bruit
III. Epidemiology
- CVAs caused by atherosclerosis of Internal Carotid Artery or intracranial arteries: 15%
IV. Symptoms
- Contralateral weakness or numbness
- Ipsilateral blindness or Amaurosis Fugax
- Dominant hemisphere involvement
V. Exam
- See Neurologic Exam
-
Carotid Bruit
- Unreliable due to low Test Sensitivity and Specificity
VI. Evaluation
- Universal Screening in asymptomatic patients does not improve outcomes
- High False Positive Rate in general population
- LeFevre (2014) An Intern Med 161(5): 356-62 [PubMed]
- Symptomatic patients with possible CVA, TIA or Amaurosis Fugax should be evaluated for Carotid Stenosis
VII. Imaging: Preferred First-Line Studies
-
Carotid Artery Duplex Ultrasonography
- Degree of stenosis is estimated from Blood Flow velocities along the carotid course
- Flow rates increase as stenosis increases
- Measurements altered in tortuous or highly calcified arteries
- Standard first-line diagnostic tool for Carotid Stenosis
- However, do not make clinical decisions based on Ultrasound alone (due to False Positives)
- Confirm findings with either a MRA or CTA
- Less expensive than MRA
- Accuracy for diagnosing severe Carotid Stenosis
- Test Sensitivity: 86%
- Test Specificity: 87%
- Degree of stenosis is estimated from Blood Flow velocities along the carotid course
- CT Angiography with 3D reconstruction
- Requires intravenous iodinated contrast exposure and radiation exposure
- Approaches 100% Test Sensitivity and Specificity when screening for mild Carotid Stenosis
- However, poorly differentiates between moderate and severe Carotid Stenosis
- Test Sensitivity: 60 to 65%
- Test Specificity: 88 to 93%
- Anderson (2000) Stroke 31:2168-74 [PubMed]
- Carotid Magnetic Resonance Angiography (MRA)
- Better than Ultrasound at defining carotid anatomy
- Accuracy for diagnosing severe Carotid Stenosis
- Test Sensitivity: 95%
- Test Specificity: 90%
- References
VIII. Imaging: Other studies
- Angiography
- Gold standard which allows evaluation of the entire carotid system
- Invasive procedure with risk of neurologic complications
- Now used primarily to resolve imaging discrepancies in perioperative period
IX. Management: Symptomatic Carotid Stenosis
- Indications for carotid endarterectomy
- Transient Ischemic Attack or CVA within prior 6 months AND
- Ipsilateral severe Carotid Artery Stenosis (>70%, consider for >50% by angiography) AND
- Estimated perioperative morbidity and mortality <6%
- https://riskcalculator.facs.org/RiskCalculator/
- Surgical risk increases with neck region related factors
- Tracheostomy or other neck surgery
- Prior neck radiation
- Restenosis of prior carotid endarterectomy
- Endarterectomy carries risk of significant morbidity
- Cognitive changes may be difficult to discern
- Risk of CVA within 30 days of procedure: 7%
- Symptomatic patient with Carotid Stenosis >70%
- Intervention offers greatest benefit (17% Absolute Risk Reduction at 2 years per NASCET study)
- Significant benefit from carotid endarterectomy
- Benefits include patients over age 75 years
- CVA will occur in 1-2% of patients with >70% stenosis who do not undergo intervention
- Symptomatic patient with Carotid Stenosis 50 to 69%
- Benefit from carotid endarterectomy
- Benefits include patients over age 75 years
- Symptomatic patient with Carotid Stenosis <50%
- No benefit from carotid endarterectomy
- See Prevention of Ischemic Stroke
X. Management: Asymptomatic Carotid Stenosis >60%
- Consider carotid endarterectomy for asymptomatic Carotid Stenosis >80%
- Medical therapy: Indicated if Carotid Stenosis <80%
- Overall CVA Risk on medical therapy: 12% CVA 5 year risk
- See Prevention of Ischemic Stroke
- Hypertension control (typical goal is <130/80)
- Exercise caution with bilateral Carotid Stenosis
- Hyperlipidemia control with Statins
- Antiplatelet options
- Aspirin
- Other antiplatelet agents are not recommended
- Clopidogrel (Plavix)
- Do not use concurrently with Aspirin
- Aspirin with Dipyridamole (Aggrenox)
- Clopidogrel (Plavix)
XI. Management: Surgical Procedures
- Overall CVA Risk on surgical therapy: 6% CVA 5 year risk
- Relative contraindications to carotid endarterectomy
- Women show less benefit in asymptomatic Carotid Stenosis
- Life Expectancy <5 years
- Active cardiovascular disease
- Age over 80 years
- Concomitant intranial stenosis
- Contralateral Carotid Stenosis
- Carotid endarterectomy
- Five year stroke risk reduction decreases with endarterectomy delay from symptom onset (>50% Carotid Stenosis)
- NNT 5 if endarterectomy performed within 2 weeks of symptom onset
- NNT 125 if endarterectomy performed within 12 weeks of symptom onset
- Complications
- Stroke or death occurs within 7% of patients in first 30 days, and 15% within 5 years
- Rerkasem (2020) Cochrane Database Syst Rev (9): CD001081 [PubMed]
- Five year stroke risk reduction decreases with endarterectomy delay from symptom onset (>50% Carotid Stenosis)
-
Angioplasty with Stent and Distal Protection
- As effective as carotid endarterectomy
- May be preferred in patients at high risk of complications due to comorbidity
- Higher risk of morbidity and mortality in first 3 months after intervention (NNH 32 compared with endarterectomy)
- Increased risk appears due to stenting of an unstable Plaque (esp. age >70 years)
- Those age <70 years have similar complication rates to carotid endarterectomy at 3 months
- After 3 months, complication rates are the same
- European trials (SPACE and EVA-3S) studies with high complication rates did not use distal protection devices
- Muller (2020) Cochrane Database Syst Rev (2): CD000515 [PubMed]
- Rantner (2013) J Vasc Surg 57(3): 619-26 [PubMed]
- Bonati (2011) Eur J Vasc Endovasc Surg 41(2): 153-8 [PubMed]
- Transcarotid Artery Revascularization
- Newer carotid revascularization procedure
- Carotid Artery clamped proximal top stenosis, artery incised and clot removed
- Trialed in patients at high risk of endarterectomy complications with stroke or death 2.3% at 30 days
XII. References
- Alamowitch (2001) Lancet 357:1154-60 [PubMed]
- Ellis (1992) Eur J Vasc Surg 6(2):172-7 [PubMed]
- Firnhaber (2022) Am Fam Physician 105(1): 65-72 [PubMed]
- Gutierrez (1985) Am Surg 51(7):388-91 [PubMed]
- Halliday (2004) Lancet 363:1491-502 [PubMed]
- Rothwell (2003) Lancet 361:107-16 [PubMed]
- Shorr (1998) J Gen Intern Med 13(2):86-90 [PubMed]